Protein critical to early stages of cellular HIV infection identified

August 8, 2017
Shortly after HIV-1 entry, MELK produced by the target cell regulates removal of the protein coat (the capsid, CA, which is an important part of the core of the virus) by adding a modification at a specific location. This regulated coat removal promotes optimal production of viral DNA, allowing the infection process to proceed efficiently. Credit: Department of Molecular Virology, TMDU

When a virus enters a cell, one of the first steps in the process of infecting that cell is removal of the protein coat that surrounds the virus's genetic material. The virus can then produce DNA from its own genes and insert it into the cell's genome. This allows the virus to hijack the host cell's machinery, forcing the cell to make copies of the virus.

HIV-1 is the most common form of HIV, the that causes AIDS. Now, a team led by researchers at Tokyo Medical and Dental University (TMDU) have identified a protein produced by the host cell that is necessary for correct removal of the protein coat of HIV-1. The study was published in PLOS Pathogens.

In their search for factors involved in HIV-1 infection, the team interfered with the activity of over 15,000 genes to identify those whose suppression allowed the to survive exposure to the virus. This led them to focus on a protein called maternal embryonic leucine-zipper kinase (MELK).

"Depleting cells of MELK reduced HIV-1 infectivity," lead and corresponding author Hiroaki Takeuchi says. "The virus entered the MELK-depleted cell normally, but its protein coat was not removed correctly so it was unable to efficiently produce DNA from its own . When we restored MELK, the infection process was also restored."

The researchers went on to investigate how MELK interferes with the protein coat removal step of infection. They discovered that MELK alters the coat by attaching a biologically active modification at a specific location. This in turn ensures correct removal of the coat. When the team engineered a mutated version of HIV-1 that was already modified at this location, they found that MELK was no longer needed for coat removal.

"Our results reveal a previously unrecognized mechanism involved in removal of the of HIV-1 and contribute to our understanding of the early stages of the viral life-cycle," corresponding authors Hiroaki Takeuchi and Shoji Yamaoka say. "Furthermore, our findings suggest that MELK is a potential target for anti-HIV-1 therapy."

Explore further: Glioblastoma: Study ties three genes to radiation resistance in recurrent tumors

More information: Hiroaki Takeuchi et al, Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006441

Related Stories

Glioblastoma: Study ties three genes to radiation resistance in recurrent tumors

February 3, 2015
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.

New Ebola study points to potential drug target

April 9, 2015
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.

Researchers identify potential Zika virus target

May 4, 2017
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating fetal malformations can develop when infection occurs during pregnancy.

Recommended for you

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.